411 related articles for article (PubMed ID: 14512884)
21. Targeted disruption of the hepatic transferrin receptor 2 gene in mice leads to iron overload.
Wallace DF; Summerville L; Subramaniam VN
Gastroenterology; 2007 Jan; 132(1):301-10. PubMed ID: 17241880
[TBL] [Abstract][Full Text] [Related]
22. Transferrin receptor 2 mediates a biphasic pattern of transferrin uptake associated with ligand delivery to multivesicular bodies.
Robb AD; Ericsson M; Wessling-Resnick M
Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1769-75. PubMed ID: 15317665
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of transferrin receptor 1 transcription by a cell density response element.
Wang J; Chen G; Pantopoulos K
Biochem J; 2005 Dec; 392(Pt 2):383-8. PubMed ID: 16092918
[TBL] [Abstract][Full Text] [Related]
24. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo.
Kawabata H; Germain RS; Vuong PT; Nakamaki T; Said JW; Koeffler HP
J Biol Chem; 2000 Jun; 275(22):16618-25. PubMed ID: 10748106
[TBL] [Abstract][Full Text] [Related]
25. Elevated levels of transferrin receptor 2 mRNA, not transferrin receptor 1 mRNA, are associated with increased survival in acute myeloid leukaemia.
Nakamaki T; Kawabata H; Saito B; Matsunawa M; Suzuki J; Adachi D; Tomoyasu S; Phillip Koeffler H
Br J Haematol; 2004 Apr; 125(1):42-9. PubMed ID: 15015967
[TBL] [Abstract][Full Text] [Related]
26. Cu loading alters expression of non-IRE regulated, but not IRE regulated, Fe dependent proteins in HepG2 cells.
Fosset C; Danzeisen R; Gambling L; McGaw BA; McArdle HJ
J Inorg Biochem; 2009 May; 103(5):709-16. PubMed ID: 19232737
[TBL] [Abstract][Full Text] [Related]
27. Transferrin receptor-1 suppresses neurite outgrowth in neuroblastoma Neuro2A cells.
Nakamura Y; Nakamichi N; Takarada T; Ogita K; Yoneda Y
Neurochem Int; 2012 Apr; 60(5):448-57. PubMed ID: 22019713
[TBL] [Abstract][Full Text] [Related]
28. Examination of the mechanism of action of nitrogen monoxide on iron uptake from transferrin.
Watts RN; Richardson DR
J Lab Clin Med; 2000 Aug; 136(2):149-56. PubMed ID: 10945243
[TBL] [Abstract][Full Text] [Related]
29. Comparative studies of the binding and growth-supportive ability of mammalian transferrins in human cells.
Penhallow RC; Brown-Mason A; Woodworth RC
J Cell Physiol; 1986 Aug; 128(2):251-60. PubMed ID: 3015988
[TBL] [Abstract][Full Text] [Related]
30. Gene expression of transferrin and transferrin receptor in brains of control vs. iron-deficient rats.
Han J; Day JR; Connor JR; Beard JL
Nutr Neurosci; 2003 Feb; 6(1):1-10. PubMed ID: 12608731
[TBL] [Abstract][Full Text] [Related]
31. Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosis.
Chua AC; Delima RD; Morgan EH; Herbison CE; Tirnitz-Parker JE; Graham RM; Fleming RE; Britton RS; Bacon BR; Olynyk JK; Trinder D
J Hepatol; 2010 Mar; 52(3):425-31. PubMed ID: 20133002
[TBL] [Abstract][Full Text] [Related]
32. Expression of the subgenomic hepatitis C virus replicon alters iron homeostasis in Huh7 cells.
Fillebeen C; Muckenthaler M; Andriopoulos B; Bisaillon M; Mounir Z; Hentze MW; Koromilas AE; Pantopoulos K
J Hepatol; 2007 Jul; 47(1):12-22. PubMed ID: 17399844
[TBL] [Abstract][Full Text] [Related]
33. Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells.
Taetle R; Honeysett JM
Cancer Res; 1987 Apr; 47(8):2040-4. PubMed ID: 3828993
[TBL] [Abstract][Full Text] [Related]
34. TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway.
Calzolari A; Raggi C; Deaglio S; Sposi NM; Stafsnes M; Fecchi K; Parolini I; Malavasi F; Peschle C; Sargiacomo M; Testa U
J Cell Sci; 2006 Nov; 119(Pt 21):4486-98. PubMed ID: 17046995
[TBL] [Abstract][Full Text] [Related]
35. Effects of transferrin-indium on cellular proliferation of a human leukemia cell line.
Moran PL; Seligman PA
Cancer Res; 1989 Aug; 49(15):4237-41. PubMed ID: 2743310
[TBL] [Abstract][Full Text] [Related]
36. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway.
Johnson MB; Chen J; Murchison N; Green FA; Enns CA
Mol Biol Cell; 2007 Mar; 18(3):743-54. PubMed ID: 17182845
[TBL] [Abstract][Full Text] [Related]
37. Non-transferrin-bound iron uptake in Belgrade and normal rat erythroid cells.
Garrick LM; Dolan KG; Romano MA; Garrick MD
J Cell Physiol; 1999 Mar; 178(3):349-58. PubMed ID: 9989781
[TBL] [Abstract][Full Text] [Related]
38. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions.
Chen J; Chloupková M; Gao J; Chapman-Arvedson TL; Enns CA
J Biol Chem; 2007 Dec; 282(51):36862-70. PubMed ID: 17956864
[TBL] [Abstract][Full Text] [Related]
39. Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice.
Okazaki F; Matsunaga N; Okazaki H; Utoguchi N; Suzuki R; Maruyama K; Koyanagi S; Ohdo S
Cancer Res; 2010 Aug; 70(15):6238-46. PubMed ID: 20631077
[TBL] [Abstract][Full Text] [Related]
40. The Cytoplasmic domain of transferrin receptor 2 dictates its stability and response to holo-transferrin in Hep3B cells.
Chen J; Enns CA
J Biol Chem; 2007 Mar; 282(9):6201-9. PubMed ID: 17202145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
